tiprankstipranks
Trending News
More News >
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM

Compare Mirum Pharmaceuticals (MIRM) vs. Competitors

Compare
729 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Mirum Pharmaceuticals
$99.27
$5.01B
-115.19
104.76%
10 Buy
0 Hold
0 Sell
Strong Buy
Arrowhead Pharmaceuticals
$66.91
$9.08B
230.42%
8 Buy
3 Hold
0 Sell
Moderate Buy
Catalyst Pharma
$24.07
$2.95B
14.05
6.04%
5 Buy
0 Hold
0 Sell
Strong Buy
Ultragenyx Pharmaceutical
$24.62
$2.35B
-43.10%
17 Buy
1 Hold
0 Sell
Strong Buy
ImmunityBio
$5.95
$6.12B
-14.15
90.10%
4 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$21.81
$2.78B
73.46
-26.79%
11 Buy
6 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MIRM
Mirum Pharmaceuticals
99.27
50.67
104.26%
ARWR
Arrowhead Pharmaceuticals
66.91
46.96
235.39%
CPRX
Catalyst Pharma
24.07
0.11
0.46%
RARE
Ultragenyx Pharmaceutical
24.62
-17.85
-42.03%
IBRX
ImmunityBio
5.95
2.79
88.29%
APLS
Apellis Pharmaceuticals
21.81
-7.66
-25.99%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts